Discounted Cash Flow (DCF) Analysis Unlevered
Octopus Biosafety SA (MLOCT.PA)
0.282 €
-0.00 (0.00%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P |
| Revenue |
|---|
| Revenue (%) |
| EBITDA |
| EBITDA (%) |
| EBIT |
| EBIT (%) |
| Depreciation |
| Depreciation (%) |
Balance Sheet Data
Year A/P |
| Total Cash |
|---|
| Total Cash (%) |
| Account Receivables |
| Account Receivables (%) |
| Inventories |
| Inventories (%) |
| Accounts Payable |
| Accounts Payable (%) |
| Capital Expenditure |
| Capital Expenditure (%) |
Weighted Average Cost Of Capital
| Share price | $ 0.282 |
|---|---|
| Beta | 1.495 |
| Diluted Shares Outstanding | 2.22 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 3.40% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 11.601 |
| Total Debt | 0.15 |
| Total Equity | 0.63 |
| Total Capital | 0.77 |
| Debt Weighting | 19.22 |
| Equity Weighting | 80.78 |
| Wacc |
Build Up Free Cash
Year A/P |
| Revenue |
|---|
| EBITDA |
| EBIT |
| Tax Rate |
| EBIAT |
| Depreciation |
| Accounts Receivable |
| Inventories |
| Accounts Payable |
| Capital Expenditure |
| UFCF |
| WACC |
| PV UFCF |
| SUM PV UFCF |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | - |
| Free cash flow (t + 1) | - |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | 0.15 |
| Equity Value | - |
| Shares Outstanding | 2.22 |
| Equity Value Per Share | - |